Medicenna Therapeutics Corp. Retained Earnings
Medicenna Therapeutics Corp. (MDNAF) had Retained Earnings of -CAD 80.98 million as of 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Notes
ifrs-full:RetainedEarnings · last filed 2023-06-27
- 2023-03-31: Retained Earnings -80.98M CAD.
- 2022-03-31: Retained Earnings -70.93M CAD.
- 2021-03-31: Retained Earnings -48.36M CAD.
- 2020-03-31: Retained Earnings -31.07M CAD.
| Period end | Retained Earnings |
|---|---|
| 2023-03-31 | -80.98M CAD 20-F · filed 2023-06-27 |
| 2022-03-31 | -70.93M CAD 20-F · filed 2023-06-27 |
| 2021-03-31 | -48.36M CAD 20-F · filed 2022-06-22 |
| 2020-03-31 | -31.07M CAD 40-F · filed 2021-05-28 |